title: Phenotypic and molecular characterization of intrauterine fetal growth restriction in interspecies sheep pregnancy.
abstract: Interspecies pregnancies between closely related species are usually performed in livestock to obtain improved and enriched offspring. Indeed, different hybrids have been obtained for research purposes since many years ago, and the maternal-fetal interactions have been studied as a possible strategy for species preservation. The aim of this study was to characterize by physiological and molecular approaches the interspecies pregnancy between bighorn sheep () and domestic sheep (). Hybrids were obtained by artificial insemination; the blood pressure and protein urine levels were measured during the last two-thirds of gestation. After parturition, offspring and placentas were weighed and measured and cotyledons were counted and weighed and their surface area determined. Plasma samples were obtained between wk 8 and 21 of gestation to assess progesterone (P4), vascular endothelial growth factor (VEGF), and placental growth factor (PlGF) levels and cell-free RNA was isolated during the same period to assess hypoxia-inducible factor-1 α (α) gene expression. Hybrid and normal pregnancies were analyzed using physiological and molecular parameters during the last two-thirds of gestation (wk 8-21). The results show that during the measurement period, ewes with a hybrid pregnancy presented normal blood pressure and no alteration in urinary protein content. However, compared with sheep with a normal pregnancy, those with a hybrid pregnancy had a decrease in fetal and placental growth as well as in the cotyledonary surface area. Furthermore, in the hybrid group, there was placental insufficiency, characterized by a decrease in P4 production, as well as indications of endothelial dysfunction, characterized an increase in plasma levels of VEGF and PlGF as well as in plasma gene expression of α. Overall, the results indicate that hybrids of and presented intrauterine growth restriction, essentially due to altered endothelial function and chronic placental insufficiency. Further studies are necessary to overcome this primary placental dysfunction and thus obtain improved offspring for future molecular and genomic evaluations.
authors.forename: A
authors.initials: A
authors.lastname: Chávez-García
authors.forename: E R
authors.initials: ER
authors.lastname: Vázquez-Martínez
authors.forename: C
authors.initials: C
authors.lastname: Murcia
authors.forename: A
authors.initials: A
authors.lastname: Rodríguez
authors.forename: M
authors.initials: M
authors.lastname: Cerbón
authors.forename: O
authors.initials: O
authors.lastname: Mejía
mesh_terms: D000818:Animals; D005260:Female; D047109:Fetal Development / Q000235:genetics; D005317:Fetal Growth Retardation / Q000235:genetics / Q000662:veterinary*; D018507:Gene Expression Regulation, Developmental; D020022:Genetic Predisposition to Disease; D006824:Hybridization, Genetic; D010920:Placenta / Q000098:blood supply; D000072483:Placenta Growth Factor; D011247:Pregnancy; D011257:Pregnancy Proteins; D011374:Progesterone / Q000378:metabolism; D012756:Sheep; D012757:Sheep Diseases / Q000235:genetics / Q000473:pathology*; D034581:Sheep, Bighorn / Q000235:genetics*; D034561:Sheep, Domestic / Q000235:genetics*; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics
chemical_list: D011257:Pregnancy Proteins; D042461:Vascular Endothelial Growth Factor A; D000072483:Placenta Growth Factor; D011374:Progesterone